SlideShare a Scribd company logo
Overview of cancer
Point to be covered 
1. Overview of cancer 
2. Types and reason of cancer 
3. Basic idea about progression of tumor 
4. Cell division 
5. Cell division regulation 
6. Genetic instability 
7. Mutation 
8. Invasion 
9. Angiogenesis 
10. Metastasis 
11. Grading and staging 
12. Treatment
Cancer 
• Cancer is a large group of diseases characterized by 
uncontrolled growth and spread of abnormal cells 
• Cancer cells: 
– Lose control over growth and multiplication 
– Do not self-destruct when they become worn out or 
damaged 
– Crowd out healthy cells
Cancer 
• Cancer cells reproduce every 2-6 
weeks 
• Size of cancer cells: 
One million cancer cells = head 
of a pin 
One billion cancer cells = a small 
grape 
• Five-year survival rate (starting 
from the time of diagnosis) 
2-6 weeks 
2-6 weeks 
2-6 weeks
Carcinogens 
• Ionising radiation – X Rays, UV light 
• Chemicals – tar from cigarettes 
• Virus infection – papilloma virus can be responsible 
for cervical cancer. 
• Hereditary predisposition – Some families are more 
susceptible LLiiffeessttyyllee 
to getting certain cancers. Remember you 
can’t inherit cancer its just that you maybe more 
susceptible to getting it. 
EEnnvviirroonnmmeenntt 
FFaammiillyy 
HHiissttoorryy
Types Cancers 
– Carcinoma: epithelial cells 
– Adenocarcinoma: glandular tissue 
– Sarcoma: connective tissue 
– Lymphoma: lymph tissue 
– Leukemia: blood forming tissue (marrow) 
– Gliomas: cancer of brain glial cells 
Carcinomas (cells that 
cover internal and external 
body surfaces) 
Lung 
Breast 
CCoolloonn 
BBllaaddddeerr 
PPrroossttaattee 
((MMeenn)) 
LLeeuukkeemmiiaa 
((BBlloooodd CCeellllss)) 
LLyymmpphhoommaass 
((LLyymmpphh nnooddeess)) 
SSaarrccoommaass 
Cells in supportive 
tissues – bones & 
muscles
Proliferation and differentiation 
• Increase in the cell 
number with exact 
passages of genetic 
information to their 
daughter cells 
• Different kinds of cells with 
the specialized morphology, 
metabolism and 
physiological functions from 
the cells of the same origin.
Hypertrophy, hyperplasia, Dysplasia vs Neoplasia
Tumor invasion of the basement membrane 
• Benign lesion characterized by the continuous 
basement membrane, that separate neoplastic 
epithelium from the stroma 
• Malignant tumor have loss of basement membrane 
around tumor cell in stromal compartment
Benign and Malignant Tumors
Normal cell 
Acquired DNA 
Successful DNA repair 
damaging agent 
i.e. chemical, 
radiation, virus DNA damage 
mutation i.e. genes 
Failure of DNA Repair 
Mutation in somatic cells 
Inactivation of tumor 
suppressor gene 
Activation of proto-oncogene 
affecting DNA repair 
and apoptosis 
pathway 
Alteration of apoptosis 
gene 
Unregulated proliferation Decreased apoptosis 
Clonal expansion 
Tumor progression 
Malignant neoplasm 
Invasion Metastasis 
•Angiogenesis 
•Escape from immunity Additional mutation
Phases of the cell cycle 
Cell cycle have two phase 
(1) S phase (Non-division phase) 
(2) Division phase (Division phase) 
Gap phase 
•G1 devoted for metabolic activity for 
cell growth and preparation for DNA 
replication 
•G2 preparation for mitotic cell 
division takes place
Cell Cycle check points 
Check Point 
Check Point 
Checks DNA damage 
Before final commitment for replication: 
defect can be repaired as chromatids are still 
together 
G1 arrest 
Checks integrity of DNA 
Check completion of DNA replication. 
Are they ready for mitosis 
G2 arrest
Control of the Cell Cycle 
The passage of a cell through the cell cycle 
is controlled by proteins in the cytoplasm. 
These protein are: 
• Cdks (Cyclin-dependent kinases) 
• Cyclins 
• CKIs(Cyclin dependent kinase inhibitor )
Complete regulation of cell cycle
CDK ( Cyclin dependent kinase) &Cyclins 
• CDK contain two parts, an enzyme 
(kinase) and a modifying protein 
(Cyclin) 
• Kinases are regulatory enzymes that 
catalyze the addition of phosphate 
groups to protein substrates 
• Cyclins synthesize and degenerate at 
each cycle, work as docking site for 
substrate 
• Cdk4 and Cdk6 regulate entry into 
cell cycle 
• Cdk1 and Cdk2 operate primarily in 
M phase and S phase
CDK ( Cyclin dependent kinase) &Cyclins 
• CDKI have capability of sensing problems 
• Kip family: P21waf1/cip1, P27kip1 ,P57kip2 
• Ink4 family: P16Ink4a,P15Ink4b,P18Ink4c,P19Ink4d 
• INK4 proteins binds to CDK 4 & 6 
• Cip –Kip proteins binds to CDK 1 & 2
Cyclins and CDKs 
Kinase 
complex 
Vertebrate Yeast 
Cyclin CDK Cyclin CDK 
G1-CDK Cyclin D* CDK4 、6 Cln 3 CDK1(CDC28) 
G1/S-CDK Cyclin E CDK2 Cln 1、 
2 
CDK1(CDC28) 
S-CDK Cyclin A CDK2 Clb 5、 
6 
CDK1(CDC28) 
M-CDK Cyclin B CDK1(CDC2 
) 
Clb 1-4 CDK1(CDC28)
Complete regulation of cell cycle
Tumor as result 
• Overexpression of cyclins 
• Overexpression of Cdks 
• Deactivation of CkIs 
• Abnormity of checkpoints
Normal cell 
Acquired DNA 
Successful DNA repair 
damaging agent 
i.e. chemical, 
radiation, virus DNA damage 
mutation i.e. genes 
Failure of DNA Repair 
Mutation in somatic cells 
Inactivation of tumor 
suppressor gene 
Activation of proto-oncogene 
affecting DNA repair 
and apoptosis 
pathway 
Alteration of apoptosis 
gene 
Unregulated proliferation Decreased apoptosis 
Clonal expansion 
Tumor progression 
Malignant neoplasm 
Invasion Metastasis 
•Angiogenesis 
•Escape from immunity Additional mutation
Signs for Genomic Changes in Cancer 
• Changes in chromosome numbers 
• Aneuploidy 
• Chromosomal changes 
- Increase in DNA copy number 
- Loss in chromosome 
• Hypermethylation at promoter region is a common mechanism 
by which tumor suppressor loci are epigenetically silenced in 
cancer cells (aberrant gene transcription)
LOH (Loss of heterozygosity) 
• LOH termed as pre-tumor cells are heterozygous for tumor suppressor gene, 
alleles of genetic marker surround the gene 
•Tumor cell will loss the normal tumor suppressor allele & surrounding markers 
too 
Pre-tumor cell Tumor cell 
Inherited Rb Second hit 
A 
Rb Rb Rb 
b 
a 
B 
A 
b
Telomere and telomerase 
•Telomer 
Telomer 6 nucleotide sequence at end of 
chromosome to avoid the chromosomal end 
to end fusion 
•Telomerase (RNA containing enzyme) 
Facilitate replication of telomer 
•Mitotic clock 
Normally telomer loss at each cell division, 
serve as cellular mitotic clock to limit no. of 
cell division and cellular life span 
•Cellular crisis 
In extended cell division, loss of capping 
resulting into chromosomal instability which 
leads to loss of cell viability and 
proliferation capacity 
Telomerase activity is detected in 80% to 90% most common 
cancer
What are the genes responsible for tumorigenic 
Normal cell growth? 
+ 
- 
Proto-oncogenes Cell growth 
Cancer 
and 
Tumor suppressor genes proliferation 
Mutated or “activated” 
oncogenes Malignant 
transformation 
Loss or mutation of 
Tumor suppressor genes 
++
List of proto-Oncogene
List of tumor suppressor gene
Mutation leads to Oncogene 
Each proto-oncogene is composed of 2 
region: 
• Structural region (SR) encodes AA 
• Regulatory region (RR) modulate 
expression as per stimuli 
Change in either SR or RR create active 
onco-gene 
Regulatory region leads to inappropriate 
level of growth inducing protein 
Structural mutation leads change in 
structure & function of protein 
Proto-oncogene 
oncogene
Ras is GTP binding protein act as digital 
switch 
Ras regulate cell growth 
– Play a role in mitogenesis by 2 
mechanism 
• Nucleotide exchange (GDP by 
GTP) 
• GTP hydrolysis ( convert active 
Ras to inactive Ras) 
Mutated Ras: 
Trapped in permanently active state due 
to loss of GTP hydrolysis through 
GAP binding 
• Leads to continuous activation of 
MAP kinase signaling
p53 maintain integrity of Genome 
• P53 mutation is common in >50% human cancer 
• Normal p53 maintain the genomic integrity via 
• Response to DNA damage (cell cycle arrest) via P21 CDK 
inhibitor 
• Inducing apoptosis 
• Disruption/deletion of p53 gene 
• Uncorrected DNA damage 
• Uncontrolled cell proliferation via decreased apoptosis
Loss of normal Apoptosis pathway 
• Inactivation of p53, leads increase in BCl-2: causes 
enhanced cell survival and genetic instability and 
clonal suspension and diversification of tumor 
without activation of death pathway
Normal cell 
Acquired DNA 
Successful DNA repair 
damaging agent 
i.e. chemical, 
radiation, virus DNA damage 
mutation i.e. genes 
Failure of DNA Repair 
Mutation in somatic cells 
Inactivation of tumor 
suppressor gene 
Activation of proto-oncogene 
affecting DNA repair 
and apoptosis 
pathway 
Alteration of apoptosis 
gene 
Unregulated proliferation Decreased apoptosis 
Clonal expansion 
Tumor progression 
Malignant neoplasm 
Invasion Metastasis 
•Angiogenesis 
•Escape from immunity Additional mutation
Invasion and Metastasis 
• Abnormal cells proliferate and 
spread (metastasize) to other 
parts of the body 
• Invasion - direct migration and 
penetration into neighboring 
tissues 
• Metastasis - cancer cells 
penetrate into lymphatic 
system and blood vessels
Cell migration via cell –cell intraction 
•Majority of cancer occur in 
epithelial cells, normally 
maintenance of cell- cell contact 
maintained by (TJ & AJ) Junction, 
which maintains by cadherin 
•Any disruption to cadherin to 
catenin results in loss of cell 
adhesion(Cadherin, integrins, 
Immunoglobulin and CD-44) 
•E-cadherin also considered as 
metastatic suppressor
Cell- ECM (Extra cellular matrix) 
interaction 
ECM provides not only scaffolding 
for the cellular constituents & also 
initiates tissue morphogenesis, 
differentiation and homeostasis 
The ECM is composed of two main 
classes 
Macromolecules: Proteoglycans 
Fibrous proteins i.e collagens, 
elastins, fibronectins and laminins 
Cell –ECM interaction mediated by 
integrins receptor present on tumor 
cell
Loss of cadherin 
•Reduces the cells to adhere each other 
•Facilitate cell detachment from tumor 
•Advancing into surrounding tissue 
Attached to the ECM component 
•Laminin of ECM bind to integrins of tumor 
• Activate the protease of tumor cell (MMPs) 
•MMPs degrades the iv collagen and release 
VEGF as angiogenic stimuli 
•MMP release activate the GF (PDGF, TGF) of ECM 
affect the growth of tumor 
•Degradation of ECM creates the passage of 
invasion & signal for angiogenesis 
Tumor progression
Angiogenesis is a normal and necessary 
process 
Angiogenesis is pivotal in:- 
•Tissue growth and development 
•Plays role in normal physiology 
•Wound healing, 
•Female reproductive cycle 
•Inflammation and embryogenesis
Angiogenesis-Pathological Disorders
VEGF helps in the formation of new blood 
vessels that support tumor growth.
Function of Angiogenic factors 
Recruitment of pericytes and 
smooth muscle cell 
Blood vessel formation 
FGF 
Tie 2 Blood vessel Stablization 
and remodeling 
Artery , vein differentiation, 
vessel remodeling 
Epherins
Angiogenesis controls tumor growth. 
Angiogenic Switch dynamic balance of pro & anti-angiogenic factor tripped in favor of 
blood vessel formation 
• Tumor can stay in a ‘dormant’ state 
for long periods. 
• The angiogenic switch allows for 
growth of the tumor to occur. 
• Increased angiogenesis correlates 
with worse prognosis.
Link b/w Inflammation & Malignancy 
Chronic inflammation leads to cancer 
• H. Pylori Stomach cancer 
• Chronic reflux esophagitis Barrett syndrome 
• Chronic pancreatitis Ca Pancreas 
• Ulcerative colitis Colon cancer 
• HCV, HBV Liver cancer (HCC)
The most common cancer arise in the skin, prostate, 
breast, lung and colon 
• More than 100 kinds of cancer 
• Most common type is skin cancer 
• Liver cancer 
• Stomach cancer 
• Prostate cancer 
• Colon, breast, and lung
Grading and staging 
• Grade: 
GX: Grade cannot be assessed 
(Undetermined grade) 
G1 Well-differentiated (Low 
grade) 
G2 Moderately differentiated 
(Intermediate grade) 
G3 Poorly differentiated (High 
grade) 
G4 Undifferentiated (High grade) 
• Staging systems 
(various): carcinoma 
– Stage 1: confined to organ 
– Stage 2: locally invasive 
– Stage 3: lymph node invasion 
– Stage 4: spread to distant sites 
Extent of the prim. tumor and extent of spread in the body 
Helps planning treatment and Prognosis
TNM - system 
• Most common (accepted by UICC, AICC) 
• Based on : T  extent of the tumor 
N  extent of spread to the lymph nodes 
M  presence of metastasis 
• Number  indicates size or extent of the prim. tumor and the extent 
of spread of metastasis
Cancer Treatment and Prevention 
When a person is diagnosed with cancer, a variety of 
weapons are available to combat it 
1-local therapy: 
• Surgery. 
• Radiation therapy 
2-systemic treatment: 
• chemotherapy. 
• Hormonal therapy 
• Monoclonal antibodies 
• Radioactive material
Detection method of Cancer 
• Amplification Technique 
• Sequencing 
• Microarray 
• Protein array 
• Tissue microarray Visualization 
• Tissue microarray analysis
Summary 
• Defect in cell division 
• Mutation 
Benign 
Tumor 
• Invasion , metastasis & Angiogenesis 
Malignant 
Tumor

More Related Content

What's hot

Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasis
Nilesh Kucha
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor gene
AJEESH BL
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesisdrmcbansal
 
Hallmarks of Cancer
Hallmarks of Cancer Hallmarks of Cancer
Hallmarks of Cancer
Dilip P Pandya
 
Multistep Carcinogenesis
Multistep CarcinogenesisMultistep Carcinogenesis
Multistep Carcinogenesis
Chetan Ganteppanavar
 
Oncogene
OncogeneOncogene
Oncogene
AshfaqAziz2
 
Molecular approaches in tumor therapy
Molecular approaches in tumor therapyMolecular approaches in tumor therapy
Molecular approaches in tumor therapy
Noakhali science and technology university
 
Anticancer resistance
Anticancer resistanceAnticancer resistance
Anticancer resistance
DRx Priya Shukla
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
Ashwini Gowda
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
Mammootty Ik
 
Cancer
CancerCancer
Molecular basis of Cancer
Molecular basis of CancerMolecular basis of Cancer
Molecular basis of Cancer
Nethravathi Siri
 
Anthracyclines
Anthracyclines Anthracyclines
Anthracyclines
Dr. Chinmayee Agrawal
 
Molecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasisMolecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasisGopi krishna Giri
 
targeted therapy
targeted therapytargeted therapy
targeted therapy
FREE EDUCATION FOR ALL
 
Molecular biology of cancer.pptx
Molecular biology of cancer.pptxMolecular biology of cancer.pptx
Molecular biology of cancer.pptx
Prosper Ingabire
 

What's hot (20)

Chapter 32 invasion and metastasis
Chapter 32 invasion and metastasisChapter 32 invasion and metastasis
Chapter 32 invasion and metastasis
 
Tumor Suppressor Gene
Tumor Suppressor GeneTumor Suppressor Gene
Tumor Suppressor Gene
 
Oncogene and tumor suppressor gene
Oncogene and tumor suppressor geneOncogene and tumor suppressor gene
Oncogene and tumor suppressor gene
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Hallmarks of Cancer
Hallmarks of Cancer Hallmarks of Cancer
Hallmarks of Cancer
 
Multistep Carcinogenesis
Multistep CarcinogenesisMultistep Carcinogenesis
Multistep Carcinogenesis
 
Oncogene
OncogeneOncogene
Oncogene
 
Molecular approaches in tumor therapy
Molecular approaches in tumor therapyMolecular approaches in tumor therapy
Molecular approaches in tumor therapy
 
Oncogenesis
OncogenesisOncogenesis
Oncogenesis
 
Cancer carcinogens
Cancer carcinogensCancer carcinogens
Cancer carcinogens
 
Anticancer resistance
Anticancer resistanceAnticancer resistance
Anticancer resistance
 
Epithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasisEpithelial and mesenchymal transition in invasion and metastasis
Epithelial and mesenchymal transition in invasion and metastasis
 
Carcinogenesis
CarcinogenesisCarcinogenesis
Carcinogenesis
 
Cancer
CancerCancer
Cancer
 
Molecular basis of Cancer
Molecular basis of CancerMolecular basis of Cancer
Molecular basis of Cancer
 
Cancer - Molecular basis
Cancer - Molecular basisCancer - Molecular basis
Cancer - Molecular basis
 
Anthracyclines
Anthracyclines Anthracyclines
Anthracyclines
 
Molecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasisMolecular mechanism of cancer metastasis
Molecular mechanism of cancer metastasis
 
targeted therapy
targeted therapytargeted therapy
targeted therapy
 
Molecular biology of cancer.pptx
Molecular biology of cancer.pptxMolecular biology of cancer.pptx
Molecular biology of cancer.pptx
 

Viewers also liked

Tumor biology
Tumor biologyTumor biology
Tumor biology
Ogunlade Timothy
 
Biology of cancer 134 L1 karobi moitra
Biology of cancer 134 L1  karobi moitraBiology of cancer 134 L1  karobi moitra
Biology of cancer 134 L1 karobi moitra
Karobi Moitra CFD, MS, PhD
 
Tumor markers
Tumor markersTumor markers
Tumor markers
Muhammed sadiq
 
1. introduction & nomenclature dr. sinhasan, mdzah
1. introduction & nomenclature dr. sinhasan, mdzah1. introduction & nomenclature dr. sinhasan, mdzah
1. introduction & nomenclature dr. sinhasan, mdzah
kciapm
 
Tnm classification in otolaryngology head &neck surgery
Tnm classification in otolaryngology head &neck surgeryTnm classification in otolaryngology head &neck surgery
Tnm classification in otolaryngology head &neck surgeryShekhar Krishna Debnath
 
Oncology Introduction.
Oncology Introduction.Oncology Introduction.
Oncology Introduction.
Shaikhani.
 
Chapter 12 gene regulation and cancer
Chapter 12 gene regulation and cancerChapter 12 gene regulation and cancer
Chapter 12 gene regulation and cancercetla1
 
Basic Cancer 2016
Basic Cancer 2016Basic Cancer 2016
Basic Cancer 2016
Robert J Miller MD
 
Tumor markers- Dr. Enja Amarnath Reddy
Tumor markers- Dr. Enja Amarnath ReddyTumor markers- Dr. Enja Amarnath Reddy
Tumor markers- Dr. Enja Amarnath Reddyapollobgslibrary
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
ABDUL QADEER MEMON
 
Extracellular matrix
Extracellular matrixExtracellular matrix
Extracellular matrixaljeirou
 
Tumor markers,AFP.CEA
Tumor markers,AFP.CEATumor markers,AFP.CEA
Tumor markers,AFP.CEA
Prashant Sharma
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzah
kciapm
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrp
Prasad CSBR
 
New TNM staging for lung cancer
New TNM staging for lung cancer New TNM staging for lung cancer
New TNM staging for lung cancer
Hussein Elkhayat
 
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...European School of Oncology
 
Tumour markers
Tumour markersTumour markers
Tumour markers
Jyotindra Singh
 

Viewers also liked (20)

Tumor biology
Tumor biologyTumor biology
Tumor biology
 
Biology of cancer 134 L1 karobi moitra
Biology of cancer 134 L1  karobi moitraBiology of cancer 134 L1  karobi moitra
Biology of cancer 134 L1 karobi moitra
 
Cancer
CancerCancer
Cancer
 
Protein syn
Protein synProtein syn
Protein syn
 
Tumor markers
Tumor markersTumor markers
Tumor markers
 
Cancer basics
Cancer basicsCancer basics
Cancer basics
 
1. introduction & nomenclature dr. sinhasan, mdzah
1. introduction & nomenclature dr. sinhasan, mdzah1. introduction & nomenclature dr. sinhasan, mdzah
1. introduction & nomenclature dr. sinhasan, mdzah
 
Tnm classification in otolaryngology head &neck surgery
Tnm classification in otolaryngology head &neck surgeryTnm classification in otolaryngology head &neck surgery
Tnm classification in otolaryngology head &neck surgery
 
Oncology Introduction.
Oncology Introduction.Oncology Introduction.
Oncology Introduction.
 
Chapter 12 gene regulation and cancer
Chapter 12 gene regulation and cancerChapter 12 gene regulation and cancer
Chapter 12 gene regulation and cancer
 
Basic Cancer 2016
Basic Cancer 2016Basic Cancer 2016
Basic Cancer 2016
 
Tumor markers- Dr. Enja Amarnath Reddy
Tumor markers- Dr. Enja Amarnath ReddyTumor markers- Dr. Enja Amarnath Reddy
Tumor markers- Dr. Enja Amarnath Reddy
 
Introduction to oncology
Introduction to oncologyIntroduction to oncology
Introduction to oncology
 
Extracellular matrix
Extracellular matrixExtracellular matrix
Extracellular matrix
 
Tumor markers,AFP.CEA
Tumor markers,AFP.CEATumor markers,AFP.CEA
Tumor markers,AFP.CEA
 
5. tumor suppressor genes dr. sinhasan, mdzah
5. tumor suppressor genes  dr. sinhasan, mdzah5. tumor suppressor genes  dr. sinhasan, mdzah
5. tumor suppressor genes dr. sinhasan, mdzah
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrp
 
New TNM staging for lung cancer
New TNM staging for lung cancer New TNM staging for lung cancer
New TNM staging for lung cancer
 
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
Medical Students 2011 - N. Pavlidis - INTRODUCTION TO CANCER TREATMENT- Basic...
 
Tumour markers
Tumour markersTumour markers
Tumour markers
 

Similar to 14 march seminar

Chapter 20
Chapter 20Chapter 20
Chapter 20
Aftab Badshah
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
RashadHamada
 
Cancer by dr.reeena
Cancer by dr.reeenaCancer by dr.reeena
Cancer by dr.reeena
Dr.reena singh
 
Chapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancerChapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancer
Nilesh Kucha
 
NEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESISNEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESIS
Dr. Roopam Jain
 
hallmarksofcancer-210603155625 (1).pdf
hallmarksofcancer-210603155625 (1).pdfhallmarksofcancer-210603155625 (1).pdf
hallmarksofcancer-210603155625 (1).pdf
AnandHosalli
 
Hallmarks of cancer
Hallmarks of cancerHallmarks of cancer
Hallmarks of cancer
InduS29
 
Tumor suppressorgenes
Tumor suppressorgenesTumor suppressorgenes
Tumor suppressorgenes
Prasad CSBR
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
MohitChauhan270470
 
cancer biology introduction and features of cancer.pptx
cancer biology  introduction and features of cancer.pptxcancer biology  introduction and features of cancer.pptx
cancer biology introduction and features of cancer.pptx
binaya tamang
 
Genomic instability and Cancer
Genomic instability and CancerGenomic instability and Cancer
Genomic instability and Cancer
Surender Rawat
 
Role of apoptosis in cancer progression
Role of apoptosis in cancer progressionRole of apoptosis in cancer progression
Role of apoptosis in cancer progression
monicka17lohan
 
CANCER...................................pptx
CANCER...................................pptxCANCER...................................pptx
CANCER...................................pptx
Cherry
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
Mohsin Shad
 
Basics in cancer biology.pdf
Basics in cancer biology.pdfBasics in cancer biology.pdf
Basics in cancer biology.pdf
SrimathideviJ
 
molecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesismolecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesis
Uday Shanker Pandey
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]
prachiupadhyay8
 
Molecular mechanism of neoplasia
Molecular mechanism of neoplasiaMolecular mechanism of neoplasia
Molecular mechanism of neoplasia
Utkarsh Sharma
 

Similar to 14 march seminar (20)

Cancer cell biology
Cancer cell biologyCancer cell biology
Cancer cell biology
 
Chapter 20
Chapter 20Chapter 20
Chapter 20
 
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssssNORMAL-CELLS-versus-CANCER-CELLS.pptxssss
NORMAL-CELLS-versus-CANCER-CELLS.pptxssss
 
Cancer by dr.reeena
Cancer by dr.reeenaCancer by dr.reeena
Cancer by dr.reeena
 
Chapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancerChapter 3 hallmarks of cancer
Chapter 3 hallmarks of cancer
 
NEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESISNEOPLASIA: CARCINOGENESIS
NEOPLASIA: CARCINOGENESIS
 
hallmarksofcancer-210603155625 (1).pdf
hallmarksofcancer-210603155625 (1).pdfhallmarksofcancer-210603155625 (1).pdf
hallmarksofcancer-210603155625 (1).pdf
 
Hallmarks of cancer
Hallmarks of cancerHallmarks of cancer
Hallmarks of cancer
 
Tumor suppressorgenes
Tumor suppressorgenesTumor suppressorgenes
Tumor suppressorgenes
 
Carcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdfCarcinomagenesis Theories .pdf
Carcinomagenesis Theories .pdf
 
cancer biology introduction and features of cancer.pptx
cancer biology  introduction and features of cancer.pptxcancer biology  introduction and features of cancer.pptx
cancer biology introduction and features of cancer.pptx
 
Genomic instability and Cancer
Genomic instability and CancerGenomic instability and Cancer
Genomic instability and Cancer
 
Role of apoptosis in cancer progression
Role of apoptosis in cancer progressionRole of apoptosis in cancer progression
Role of apoptosis in cancer progression
 
CANCER...................................pptx
CANCER...................................pptxCANCER...................................pptx
CANCER...................................pptx
 
Molecular Basis of Cancer
 Molecular Basis of Cancer Molecular Basis of Cancer
Molecular Basis of Cancer
 
Basics in cancer biology.pdf
Basics in cancer biology.pdfBasics in cancer biology.pdf
Basics in cancer biology.pdf
 
Oncogenes
OncogenesOncogenes
Oncogenes
 
molecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesismolecular pathogenesis of carcinogenesis
molecular pathogenesis of carcinogenesis
 
Cancer genetics [autosaved]
Cancer genetics [autosaved]Cancer genetics [autosaved]
Cancer genetics [autosaved]
 
Molecular mechanism of neoplasia
Molecular mechanism of neoplasiaMolecular mechanism of neoplasia
Molecular mechanism of neoplasia
 

More from Pooja Goswami

Vaccine 5 march
Vaccine 5 march Vaccine 5 march
Vaccine 5 march
Pooja Goswami
 
23 jan final slides copy (dr pooja-vaio's conflicted copy 2013-12-14)
23 jan final slides   copy (dr pooja-vaio's conflicted copy 2013-12-14)23 jan final slides   copy (dr pooja-vaio's conflicted copy 2013-12-14)
23 jan final slides copy (dr pooja-vaio's conflicted copy 2013-12-14)
Pooja Goswami
 
Final 27 aug seminr
Final 27 aug seminrFinal 27 aug seminr
Final 27 aug seminr
Pooja Goswami
 
Final seminar 1 oct 13
Final seminar  1 oct 13Final seminar  1 oct 13
Final seminar 1 oct 13
Pooja Goswami
 
Final slides today 5 feb 13
Final slides   today 5 feb 13 Final slides   today 5 feb 13
Final slides today 5 feb 13
Pooja Goswami
 
Digestive system and its disease
Digestive system and its diseaseDigestive system and its disease
Digestive system and its disease
Pooja Goswami
 

More from Pooja Goswami (6)

Vaccine 5 march
Vaccine 5 march Vaccine 5 march
Vaccine 5 march
 
23 jan final slides copy (dr pooja-vaio's conflicted copy 2013-12-14)
23 jan final slides   copy (dr pooja-vaio's conflicted copy 2013-12-14)23 jan final slides   copy (dr pooja-vaio's conflicted copy 2013-12-14)
23 jan final slides copy (dr pooja-vaio's conflicted copy 2013-12-14)
 
Final 27 aug seminr
Final 27 aug seminrFinal 27 aug seminr
Final 27 aug seminr
 
Final seminar 1 oct 13
Final seminar  1 oct 13Final seminar  1 oct 13
Final seminar 1 oct 13
 
Final slides today 5 feb 13
Final slides   today 5 feb 13 Final slides   today 5 feb 13
Final slides today 5 feb 13
 
Digestive system and its disease
Digestive system and its diseaseDigestive system and its disease
Digestive system and its disease
 

Recently uploaded

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 

Recently uploaded (20)

KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 

14 march seminar

  • 2. Point to be covered 1. Overview of cancer 2. Types and reason of cancer 3. Basic idea about progression of tumor 4. Cell division 5. Cell division regulation 6. Genetic instability 7. Mutation 8. Invasion 9. Angiogenesis 10. Metastasis 11. Grading and staging 12. Treatment
  • 3. Cancer • Cancer is a large group of diseases characterized by uncontrolled growth and spread of abnormal cells • Cancer cells: – Lose control over growth and multiplication – Do not self-destruct when they become worn out or damaged – Crowd out healthy cells
  • 4. Cancer • Cancer cells reproduce every 2-6 weeks • Size of cancer cells: One million cancer cells = head of a pin One billion cancer cells = a small grape • Five-year survival rate (starting from the time of diagnosis) 2-6 weeks 2-6 weeks 2-6 weeks
  • 5. Carcinogens • Ionising radiation – X Rays, UV light • Chemicals – tar from cigarettes • Virus infection – papilloma virus can be responsible for cervical cancer. • Hereditary predisposition – Some families are more susceptible LLiiffeessttyyllee to getting certain cancers. Remember you can’t inherit cancer its just that you maybe more susceptible to getting it. EEnnvviirroonnmmeenntt FFaammiillyy HHiissttoorryy
  • 6. Types Cancers – Carcinoma: epithelial cells – Adenocarcinoma: glandular tissue – Sarcoma: connective tissue – Lymphoma: lymph tissue – Leukemia: blood forming tissue (marrow) – Gliomas: cancer of brain glial cells Carcinomas (cells that cover internal and external body surfaces) Lung Breast CCoolloonn BBllaaddddeerr PPrroossttaattee ((MMeenn)) LLeeuukkeemmiiaa ((BBlloooodd CCeellllss)) LLyymmpphhoommaass ((LLyymmpphh nnooddeess)) SSaarrccoommaass Cells in supportive tissues – bones & muscles
  • 7. Proliferation and differentiation • Increase in the cell number with exact passages of genetic information to their daughter cells • Different kinds of cells with the specialized morphology, metabolism and physiological functions from the cells of the same origin.
  • 9. Tumor invasion of the basement membrane • Benign lesion characterized by the continuous basement membrane, that separate neoplastic epithelium from the stroma • Malignant tumor have loss of basement membrane around tumor cell in stromal compartment
  • 11. Normal cell Acquired DNA Successful DNA repair damaging agent i.e. chemical, radiation, virus DNA damage mutation i.e. genes Failure of DNA Repair Mutation in somatic cells Inactivation of tumor suppressor gene Activation of proto-oncogene affecting DNA repair and apoptosis pathway Alteration of apoptosis gene Unregulated proliferation Decreased apoptosis Clonal expansion Tumor progression Malignant neoplasm Invasion Metastasis •Angiogenesis •Escape from immunity Additional mutation
  • 12. Phases of the cell cycle Cell cycle have two phase (1) S phase (Non-division phase) (2) Division phase (Division phase) Gap phase •G1 devoted for metabolic activity for cell growth and preparation for DNA replication •G2 preparation for mitotic cell division takes place
  • 13. Cell Cycle check points Check Point Check Point Checks DNA damage Before final commitment for replication: defect can be repaired as chromatids are still together G1 arrest Checks integrity of DNA Check completion of DNA replication. Are they ready for mitosis G2 arrest
  • 14. Control of the Cell Cycle The passage of a cell through the cell cycle is controlled by proteins in the cytoplasm. These protein are: • Cdks (Cyclin-dependent kinases) • Cyclins • CKIs(Cyclin dependent kinase inhibitor )
  • 16. CDK ( Cyclin dependent kinase) &Cyclins • CDK contain two parts, an enzyme (kinase) and a modifying protein (Cyclin) • Kinases are regulatory enzymes that catalyze the addition of phosphate groups to protein substrates • Cyclins synthesize and degenerate at each cycle, work as docking site for substrate • Cdk4 and Cdk6 regulate entry into cell cycle • Cdk1 and Cdk2 operate primarily in M phase and S phase
  • 17. CDK ( Cyclin dependent kinase) &Cyclins • CDKI have capability of sensing problems • Kip family: P21waf1/cip1, P27kip1 ,P57kip2 • Ink4 family: P16Ink4a,P15Ink4b,P18Ink4c,P19Ink4d • INK4 proteins binds to CDK 4 & 6 • Cip –Kip proteins binds to CDK 1 & 2
  • 18. Cyclins and CDKs Kinase complex Vertebrate Yeast Cyclin CDK Cyclin CDK G1-CDK Cyclin D* CDK4 、6 Cln 3 CDK1(CDC28) G1/S-CDK Cyclin E CDK2 Cln 1、 2 CDK1(CDC28) S-CDK Cyclin A CDK2 Clb 5、 6 CDK1(CDC28) M-CDK Cyclin B CDK1(CDC2 ) Clb 1-4 CDK1(CDC28)
  • 20. Tumor as result • Overexpression of cyclins • Overexpression of Cdks • Deactivation of CkIs • Abnormity of checkpoints
  • 21. Normal cell Acquired DNA Successful DNA repair damaging agent i.e. chemical, radiation, virus DNA damage mutation i.e. genes Failure of DNA Repair Mutation in somatic cells Inactivation of tumor suppressor gene Activation of proto-oncogene affecting DNA repair and apoptosis pathway Alteration of apoptosis gene Unregulated proliferation Decreased apoptosis Clonal expansion Tumor progression Malignant neoplasm Invasion Metastasis •Angiogenesis •Escape from immunity Additional mutation
  • 22. Signs for Genomic Changes in Cancer • Changes in chromosome numbers • Aneuploidy • Chromosomal changes - Increase in DNA copy number - Loss in chromosome • Hypermethylation at promoter region is a common mechanism by which tumor suppressor loci are epigenetically silenced in cancer cells (aberrant gene transcription)
  • 23. LOH (Loss of heterozygosity) • LOH termed as pre-tumor cells are heterozygous for tumor suppressor gene, alleles of genetic marker surround the gene •Tumor cell will loss the normal tumor suppressor allele & surrounding markers too Pre-tumor cell Tumor cell Inherited Rb Second hit A Rb Rb Rb b a B A b
  • 24. Telomere and telomerase •Telomer Telomer 6 nucleotide sequence at end of chromosome to avoid the chromosomal end to end fusion •Telomerase (RNA containing enzyme) Facilitate replication of telomer •Mitotic clock Normally telomer loss at each cell division, serve as cellular mitotic clock to limit no. of cell division and cellular life span •Cellular crisis In extended cell division, loss of capping resulting into chromosomal instability which leads to loss of cell viability and proliferation capacity Telomerase activity is detected in 80% to 90% most common cancer
  • 25. What are the genes responsible for tumorigenic Normal cell growth? + - Proto-oncogenes Cell growth Cancer and Tumor suppressor genes proliferation Mutated or “activated” oncogenes Malignant transformation Loss or mutation of Tumor suppressor genes ++
  • 27. List of tumor suppressor gene
  • 28. Mutation leads to Oncogene Each proto-oncogene is composed of 2 region: • Structural region (SR) encodes AA • Regulatory region (RR) modulate expression as per stimuli Change in either SR or RR create active onco-gene Regulatory region leads to inappropriate level of growth inducing protein Structural mutation leads change in structure & function of protein Proto-oncogene oncogene
  • 29. Ras is GTP binding protein act as digital switch Ras regulate cell growth – Play a role in mitogenesis by 2 mechanism • Nucleotide exchange (GDP by GTP) • GTP hydrolysis ( convert active Ras to inactive Ras) Mutated Ras: Trapped in permanently active state due to loss of GTP hydrolysis through GAP binding • Leads to continuous activation of MAP kinase signaling
  • 30. p53 maintain integrity of Genome • P53 mutation is common in >50% human cancer • Normal p53 maintain the genomic integrity via • Response to DNA damage (cell cycle arrest) via P21 CDK inhibitor • Inducing apoptosis • Disruption/deletion of p53 gene • Uncorrected DNA damage • Uncontrolled cell proliferation via decreased apoptosis
  • 31. Loss of normal Apoptosis pathway • Inactivation of p53, leads increase in BCl-2: causes enhanced cell survival and genetic instability and clonal suspension and diversification of tumor without activation of death pathway
  • 32. Normal cell Acquired DNA Successful DNA repair damaging agent i.e. chemical, radiation, virus DNA damage mutation i.e. genes Failure of DNA Repair Mutation in somatic cells Inactivation of tumor suppressor gene Activation of proto-oncogene affecting DNA repair and apoptosis pathway Alteration of apoptosis gene Unregulated proliferation Decreased apoptosis Clonal expansion Tumor progression Malignant neoplasm Invasion Metastasis •Angiogenesis •Escape from immunity Additional mutation
  • 33. Invasion and Metastasis • Abnormal cells proliferate and spread (metastasize) to other parts of the body • Invasion - direct migration and penetration into neighboring tissues • Metastasis - cancer cells penetrate into lymphatic system and blood vessels
  • 34. Cell migration via cell –cell intraction •Majority of cancer occur in epithelial cells, normally maintenance of cell- cell contact maintained by (TJ & AJ) Junction, which maintains by cadherin •Any disruption to cadherin to catenin results in loss of cell adhesion(Cadherin, integrins, Immunoglobulin and CD-44) •E-cadherin also considered as metastatic suppressor
  • 35. Cell- ECM (Extra cellular matrix) interaction ECM provides not only scaffolding for the cellular constituents & also initiates tissue morphogenesis, differentiation and homeostasis The ECM is composed of two main classes Macromolecules: Proteoglycans Fibrous proteins i.e collagens, elastins, fibronectins and laminins Cell –ECM interaction mediated by integrins receptor present on tumor cell
  • 36. Loss of cadherin •Reduces the cells to adhere each other •Facilitate cell detachment from tumor •Advancing into surrounding tissue Attached to the ECM component •Laminin of ECM bind to integrins of tumor • Activate the protease of tumor cell (MMPs) •MMPs degrades the iv collagen and release VEGF as angiogenic stimuli •MMP release activate the GF (PDGF, TGF) of ECM affect the growth of tumor •Degradation of ECM creates the passage of invasion & signal for angiogenesis Tumor progression
  • 37. Angiogenesis is a normal and necessary process Angiogenesis is pivotal in:- •Tissue growth and development •Plays role in normal physiology •Wound healing, •Female reproductive cycle •Inflammation and embryogenesis
  • 39. VEGF helps in the formation of new blood vessels that support tumor growth.
  • 40. Function of Angiogenic factors Recruitment of pericytes and smooth muscle cell Blood vessel formation FGF Tie 2 Blood vessel Stablization and remodeling Artery , vein differentiation, vessel remodeling Epherins
  • 41. Angiogenesis controls tumor growth. Angiogenic Switch dynamic balance of pro & anti-angiogenic factor tripped in favor of blood vessel formation • Tumor can stay in a ‘dormant’ state for long periods. • The angiogenic switch allows for growth of the tumor to occur. • Increased angiogenesis correlates with worse prognosis.
  • 42. Link b/w Inflammation & Malignancy Chronic inflammation leads to cancer • H. Pylori Stomach cancer • Chronic reflux esophagitis Barrett syndrome • Chronic pancreatitis Ca Pancreas • Ulcerative colitis Colon cancer • HCV, HBV Liver cancer (HCC)
  • 43. The most common cancer arise in the skin, prostate, breast, lung and colon • More than 100 kinds of cancer • Most common type is skin cancer • Liver cancer • Stomach cancer • Prostate cancer • Colon, breast, and lung
  • 44. Grading and staging • Grade: GX: Grade cannot be assessed (Undetermined grade) G1 Well-differentiated (Low grade) G2 Moderately differentiated (Intermediate grade) G3 Poorly differentiated (High grade) G4 Undifferentiated (High grade) • Staging systems (various): carcinoma – Stage 1: confined to organ – Stage 2: locally invasive – Stage 3: lymph node invasion – Stage 4: spread to distant sites Extent of the prim. tumor and extent of spread in the body Helps planning treatment and Prognosis
  • 45. TNM - system • Most common (accepted by UICC, AICC) • Based on : T  extent of the tumor N  extent of spread to the lymph nodes M  presence of metastasis • Number  indicates size or extent of the prim. tumor and the extent of spread of metastasis
  • 46. Cancer Treatment and Prevention When a person is diagnosed with cancer, a variety of weapons are available to combat it 1-local therapy: • Surgery. • Radiation therapy 2-systemic treatment: • chemotherapy. • Hormonal therapy • Monoclonal antibodies • Radioactive material
  • 47. Detection method of Cancer • Amplification Technique • Sequencing • Microarray • Protein array • Tissue microarray Visualization • Tissue microarray analysis
  • 48. Summary • Defect in cell division • Mutation Benign Tumor • Invasion , metastasis & Angiogenesis Malignant Tumor

Editor's Notes

  1. Cancers are capable of spreading through the body by two mechanisms: invasion and metastasis. Invasion refers to the direct migration and penetration by cancer cells into neighboring tissues. Metastasis refers to the ability of cancer cells to penetrate into lymphatic and blood vessels, circulate through the bloodstream, and then invade normal tissues elsewhere in the body.